HFZS
839725
Henan Liliang Diamond
301071
Hainan Poly Pharm
300630
Sf Diamond Co., Ltd.
300179
Jiangsu Zhengdan Chemical Industry
300641
CN Stock MarketDetailed Quotes
000991 Tonghai High Technology
- 0.00
- 0.000.00%
Trading Dec 23 09:30 CST
0Market Cap0.00P/E (TTM)
0.00High0.00Low0lotVolume0.00Open0.00Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.0052wk High0.00P/B0Float Cap0.0052wk Low0.00Limit Up0Shs Float0.00Historical High0.00Limit Down0.00%Amplitude0.00Historical Low--Dividend TTM--Avg Price0lotAsk--Div YieldTTM100Lot Size0lotBid
Tonghai High Technology Key Stats
All
YOY
| (FY)Dec 31, 1999 | (FY)Dec 31, 1998 | (FY)Dec 31, 1997 | |
|---|---|---|---|
| Assets | |||
| Current assets | |||
| Money funds | -75.63%9.48M | 237.92%38.91M | --11.51M |
| Notes receivable and accounts receivable | 114.29%90M | 21,936.33%42M | ---192.34K |
| -Notes receivable | 114.29%90M | 21,936.33%42M | ---192.34K |
| -Accounts receivable | --0 | --0 | --0 |
| Advance payment | --245.27M | --0 | --2.91M |
| Inventories | -72.32%105.82M | 3,159.90%382.33M | --11.73M |
| Deferred expense | 303.10%587.59K | -68.94%145.77K | --469.27K |
| Exceptional items of current assets | -29.79%349.61M | 14.03%497.95M | --436.67M |
| Total current assets | -16.70%800.78M | 107.59%961.33M | --463.1M |
| Non Current assets | |||
| Long-term equity investment | 1,566.38%184.89M | -152.72%-12.61M | --23.91M |
| Fixed assets | 138.78%366.23M | 563.72%153.37M | --23.11M |
| Constru in process | -99.58%1.02M | 59,301.24%246.2M | --414.47K |
| Intangible assets | -2.02%73.84M | --75.36M | ---- |
| Long deferred expense | 1,357.42%4.42M | --303.32K | ---- |
| Exceptional items of non current assets | -20.00%7.69M | --9.61M | ---- |
| Total non current assets | 35.12%638.09M | 895.50%472.24M | --47.44M |
| Total assets | 0.37%1.44B | 180.80%1.43B | --510.54M |
| Liabilities | |||
| Current liabilities | |||
| Short term loan | 134.33%389.72M | 161.69%166.31M | --63.55M |
| Notes payable and accounts payable | -74.36%103.23M | 21.95%402.69M | --330.2M |
| -Notes payable | --0 | --1.56M | --0 |
| -Accounts payable | -74.26%103.23M | 21.48%401.13M | --330.2M |
| Advance receipts | -6.49%5.14M | 92.34%5.5M | --2.86M |
| Salaries payable | 26.39%4.02M | 110.86%3.18M | --1.51M |
| Taxs payable | 12.26%85.29M | 302.93%75.97M | --18.85M |
| Other payable (including interest and dividends) | 25.70%118.35M | 906.63%94.15M | --9.35M |
| -Dividend payable | -63.33%11.11M | --30.28M | ---- |
| -Other payable | 67.91%107.25M | 582.88%63.87M | --9.35M |
| Accrued expense | 390.22%8.64M | -81.02%1.76M | --9.29M |
| Adjustment items of current assets | ---90K | ---- | ---- |
| Total current liabilities | -4.70%714.3M | 72.07%749.56M | --435.61M |
| Current liabilities | |||
| Long term loan | --0 | --0 | --30K |
| Long term account payable | -27.63%151.08M | --208.77M | ---- |
| Exceptional items of non current liabilities | 40.92%362.71K | 80.82%257.39K | --142.35K |
| Total non current liabilities | -27.55%151.45M | 121,181.42%209.02M | --172.35K |
| Total liabilities | -9.68%865.74M | 119.97%958.58M | --435.78M |
| Shareholders equity | |||
| Paid-in capital | 0.00%350M | --350M | ---- |
| Capital reserve funds | 0.00%89.17M | --89.17M | ---- |
| Surplus reserve funds | 145.00%42.52M | --17.35M | ---- |
| Retained profit | 600.45%77.16M | --11.02M | ---- |
| Attributable parent company shareholders equity adjustment items | ---- | ---- | --69.47M |
| Shareholders equity without minority interests | 19.53%558.84M | 573.02%467.54M | --69.47M |
| Minority interests | 91.70%14.28M | 41.02%7.45M | --5.28M |
| Total shareholder equity | 20.66%573.13M | 535.41%474.99M | --74.75M |
| Total liabilityies and equity | 0.37%1.44B | 180.80%1.43B | --510.54M |
| Currency Unit | CNY | CNY | CNY |
| Accounting Standards | CAS (1993) | CAS (1993) | CAS (1993) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.